Key result
This review summarizes the preclinical and clinical development of the SYNERGY bioresorbable polymer metallic coronary stent and its integration into clinical practice.
This review provides a comprehensive overview of the development and clinical integration of the SYNERGY bioresorbable polymer metallic coronary stent.
Supports informed stent selection in PCI; leaves open need for long-term comparative data.
The SYNERGY stent is composed of thin, platinum-chromium metal alloy struts and an ultrathin, bioabsorbable poly-DL-lactide-co-glycolide polymer limited to the abluminal strut surface which elutes everolimus prior to complete resorption within 3-4 months. SYNERGY was designed to reduce inflammation and facilitate stent healing compared with permanent polymer drug eluting stents. This review summarizes the preclinical and clinical development of SYNERGY, its integration into clinical practice and future directions.
No takes yet. Share an insight, caveat, or question.
Shreenivas et al. (2018) reported a review. SYNERGY bioresorbable polymer metallic coronary stent vs. permanent polymer drug eluting stents was evaluated. This review summarizes the preclinical and clinical development of the SYNERGY bioresorbable polymer metallic coronary stent and its integration into clinical practice.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: